Document Type
Article
Publication Date
5-18-2009
Abstract
Decorin, a member of the small leucine-rich proteoglycan gene family, impedes tumor cell growth by down-regulating the epidermal growth factor receptor. Decorin has a complex binding repertoire, thus, we predicted that decorin would modulate the bioactivity of other tyrosine kinase receptors. We discovered that decorin binds directly and with high affinity (K(d) = approximately 1.5 nM) to Met, the receptor for hepatocyte growth factor (HGF). Binding of decorin to Met is efficiently displaced by HGF and less efficiently by internalin B, a bacterial Met ligand. Interaction of decorin with Met induces transient receptor activation, recruitment of the E3 ubiquitin ligase c-Cbl, and rapid intracellular degradation of Met (half-life = approximately 6 min). Decorin suppresses intracellular levels of beta-catenin, a known downstream Met effector, and inhibits Met-mediated cell migration and growth. Thus, by antagonistically targeting multiple tyrosine kinase receptors, decorin contributes to reduction in primary tumor growth and metastastic spreading.
Recommended Citation
Goldoni, Silvia; Humphries, Ashley; Nyström, Alexander; Sattar, Sampurna; Owens, Rick T; McQuillan, David J; Ireton, Keith; and Iozzo, Renato V, "Decorin is a novel antagonistic ligand of the Met receptor." (2009). Department of Pathology, Anatomy, and Cell Biology Faculty Papers. Paper 104.
https://jdc.jefferson.edu/pacbfp/104
PubMed ID
19433454
Comments
This article has been peer reviewed. It was published in: Journal of Cell Biology.
Volume 185, Issue 4, 18 May 2009, Pages 743-754
The published version is available at DOI: 10.1083/jcb.200901129. Copyright © Rockerfeller University Press.